New Delhi: Cadila Healthcare or Zydus Cadila has announced to launch an oral therapy SoviHep for the treatment of Hepatitis C. It is the Ahmedabad-based pharma major Cadila Healthcare has launched Hepatitis C drug and would be marketed by the ... Odisha Samaya, 1 month ago
Zydus Cadila Launches Generic Version of Gilead Sciences Hepatitis C drug in India - Topnews.in, 1 month ago
Cadila Healthcare announces launch of SoviHep - breakthrough therapy for Hepatitis C - HDFC Securities, 1 month ago
Zydus Group to Donate USD 240,000 to The National Institutes of Health, USA for Advancing Leishmaniasis Research
/PRNewswire/ -- Etna Biotech, the Vaccine R & D subsidiary of Zydus, announced a collaborative program with the National Institute of Allergy and Infectious Diseases, part of the U.S. National Institutes of Health, for advancing leishmaniasis ...Wall Street Business Network, 4 days ago
New Delhi : Cadila Healthcare Ltd plans to seek "an enabling approval" from its shareholders to raise up to Rs 10,000 crore via issue of different securities. The company's board, which met on Wednesday, decided to seek shareholders' nod to issue ...NDTV Profit, 2 weeks ago Cadila to seek shareholders' nod to raise up to Rs 10,000 crore Jagran Post, 2 weeks ago
Cadila Healthcare gains on announcing a collaborative program with the National Institute of Alle...
Cadila Healthcare is currently trading at Rs. 1755.80, up by 7.35 points or 0.42 % from its previous closing of Rs. 1748.45 on the BSE. The scrip opened at Rs. 1770.00 and has touched a high and low of Rs. 1770.00 and Rs. 1742.20 respectively. So ...Arihant Capital, 4 days ago Cadila Healthcare gains on inking non-exclusive licensing pact with Gilead Sciences Arihant Capital, 1 month ago Zydus Cadila, Gilead Sciences ink non-exclusive licensing pact Indian-Commodity, 1 month ago
Pharmaceuticals major Zydus today said that its R&D subsidiary Etna Biotech will collaborate with US-based National Institute of Allergy and Infectious Diseases (NIAD) to develop a vaccine against visceral leishmaniasis (VL), known as Kala-Azar in ...Hindu Business Line, 4 days ago Zydus ties up with US-based research centre to develop vaccine Daily Excelsior.com, 3 days ago Zydus ties up with US-based RD centre to develop vaccine Moneycontrol.com, 4 days ago
News Top News Top Story India Infoline News Service | Mumbai | March 18, 2015 09:36 IST New drug launch by Zydus group boosts sentiment at the counter. Cadila Healthcare spurted ...India Infoline, 1 month ago
Secondary private equity transactions seem to be on the rise in India's healthcare space. Capital International, a global private equity (PE) fund, is learnt to be in talks to acquire a 11 per cent stake in Delhi-based Mankind Pharma for Rs ...Business Standard India, 2 months ago
Top News Dr. Reddy's Lab, Promius Pharma announces filing of three NDAs with USFDA Dr. Reddy's Laboratories and its subsidiary, Promius Pharma, LLC announced the filing of three 505(b)(2) New Drug Applications (NDAs) with the U.S. Food and Drug ...India Infoline, 2 weeks ago
/PRNewswire/ -- Report Details Generic Drugs - new study showing you trends, R&D progress, and predicted revenues Where is the market for generic drugs heading? What are the commercial prospects for this market and related technologies? ...Tamar Securities, 2 weeks ago
(MENAFN Press) Cancer occurs when after cell transformation normal cells grow and multiply without control. Lung cancer is a common cause of mortality and morbidity in developed and developing countries. Smoking is considered to be the major cause ...MENAFN, 3 weeks ago Global Small Cell Lung Cancer Therapeutics Market 2015-2019 MarketResearch.com, 1 month ago
on your WebpageAdd Widget >Get your members hooked!